What is Northland Capmk’s Forecast for Transcat Q3 Earnings?

Transcat, Inc. (NASDAQ:TRNS) – Investment analysts at Northland Capmk issued their Q3 2025 earnings per share estimates for shares of Transcat in a report released on Wednesday, October 30th. Northland Capmk analyst E. Jackson forecasts that the scientific and technical instruments company will post earnings of $0.41 per share for the quarter. The consensus estimate for Transcat’s current full-year earnings is $2.06 per share. Northland Capmk also issued estimates for Transcat’s Q4 2025 earnings at $0.63 EPS and FY2029 earnings at $3.45 EPS.

Other research analysts also recently issued research reports about the stock. StockNews.com downgraded shares of Transcat from a “hold” rating to a “sell” rating in a report on Tuesday. HC Wainwright reissued a “buy” rating and set a $156.00 target price on shares of Transcat in a research report on Tuesday. Northland Securities cut their price target on Transcat from $130.00 to $110.00 and set a “market perform” rating for the company in a report on Wednesday. Craig Hallum decreased their price objective on Transcat from $138.00 to $113.00 and set a “buy” rating on the stock in a report on Wednesday. Finally, Oppenheimer reaffirmed an “outperform” rating and issued a $130.00 target price (down from $155.00) on shares of Transcat in a research report on Wednesday. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, Transcat has an average rating of “Hold” and an average price target of $127.25.

Transcat Trading Down 3.5 %

Shares of TRNS stock opened at $95.57 on Thursday. Transcat has a 1 year low of $84.45 and a 1 year high of $147.12. The firm’s fifty day simple moving average is $122.34 and its 200 day simple moving average is $121.99. The firm has a market capitalization of $874.47 million, a P/E ratio of 56.55 and a beta of 0.67.

Transcat (NASDAQ:TRNS) last issued its quarterly earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 EPS for the quarter, missing the consensus estimate of $0.47 by ($0.12). Transcat had a return on equity of 8.48% and a net margin of 5.69%. The business had revenue of $67.83 million during the quarter, compared to the consensus estimate of $70.30 million. During the same period in the prior year, the firm earned $0.41 earnings per share. The business’s quarterly revenue was up 8.0% on a year-over-year basis.

Hedge Funds Weigh In On Transcat

A number of hedge funds have recently modified their holdings of the stock. DekaBank Deutsche Girozentrale acquired a new stake in Transcat in the 2nd quarter valued at $40,000. nVerses Capital LLC acquired a new stake in shares of Transcat in the 3rd quarter valued at $60,000. First Horizon Advisors Inc. grew its holdings in shares of Transcat by 26.4% in the 2nd quarter. First Horizon Advisors Inc. now owns 599 shares of the scientific and technical instruments company’s stock worth $72,000 after purchasing an additional 125 shares during the last quarter. Fifth Third Bancorp increased its position in shares of Transcat by 95.8% during the 2nd quarter. Fifth Third Bancorp now owns 656 shares of the scientific and technical instruments company’s stock worth $79,000 after purchasing an additional 321 shares in the last quarter. Finally, Quest Partners LLC bought a new position in Transcat during the 2nd quarter valued at about $109,000. 98.34% of the stock is owned by institutional investors and hedge funds.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.